Browsing “Uncategorized | EVERSANA”

EPP’s Dynamics Talks | Life Sciences

Join EVERSANA’s Ed Corbett, Head of EMEA, at the upcoming European Pricing Platform’s Dynamic Talks series on November 5, 2020, at 3 PM CET / 2 PM BST / 9 AM EST. Register NOW! Achieving Launch Excellence in a Disrupted World Developing strategies focused on demonstrating real value and minimising risk Understanding the future of […]

DSCSA Guidelines – October Update

On November 27, 2023, all drug manufacturers must participate in an electronic package-level traceability system, commonly known as the “interoperability” requirement. EVERSANA is equipped to help manufacturers navigate this new guidelines and apply best practices. Let’s work together to make sure that you stay in compliance with the FDA and meet the demands of your […]

EVERSANA Hosts Expert Roundtable: The U.S. Pharmaceutical Market Outlook

Join Dr. Kathleen Sebelius, Former United States Secretary of Health and Human Services; Joe Jimenez, Former CEO of Novartis and Co-Founder & Managing Director of Aditum Bio; Kabir Nath, President and CEO of Otsuka North America; and Jim Lang, EVERSANA’s CEO, at our expert virtual roundtable on October 29, 2020 at 4 PM CET, 3 PM […]

EVERSANA Sponsors the Orphan Drugs & Rare Diseases Congress Series

EVERSANA is proud to be a Global Sponsor at this year’s Orphan Drugs & Rare Diseases Congress series to provide a comprehensive overview of the critical issues shaping the future of 0rphan drugs. We are on a mission to advance the drug development and commercialization of orphan drugs. Together with our clients, we aim to […]

COMMERCIALIZATION OF DIGITAL THERAPEUTICS

ADVANCING THE COMMERCIALIZATION OF DIGITAL THERAPEUTICS Join EVERSANA at a number of virtual events as we work to advance the commercialization of digital medicines. “While advancements in digital medicine take us into a new frontier, these devices can and should be available through existing prescription, distribution and reimbursement infrastructures. The commercial model for digital medicine […]

EVERSANA Sponsors CBI’s HUB, SPP and e-Services Conference

Accelerating the prescribing process through enhanced access support CBI’s annual Hub and SPP conference is the gold standard event convening key stakeholders – manufacturers, specialty pharmacies, hubs, payers, PBMs and physicians – to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and maximized reimbursement. Join the EVERSANA […]

EVERSANA Sponsors the Rare Diseases and Orphan Products Breakthrough Summit

Getting Rare Disease Patients on Therapies Faster The National Organization for Rare Disorders (NORD) is leading the fight to improve the lives of rare disease patients and their families. NORD is committed to accelerating research, raising awareness, providing valuable information and driving public policy to benefit the millions of Americans impacted by rare diseases. As […]

EVERSANA Sponsors Global Genes LIVE! Patient Advocacy (un)Summit

Join EVERSANA on September 15-25 at Global Genes LIVE! A RARE Patient Advocacy (un)Summit. This two-week event will provide the rare disease community, stakeholders and allies with opportunities to connect and engage. Participants will gain insights about the latest in rare disease innovations, advocacy best practices and strategic ways to accelerate change. For the 400 […]

Workshop: How to Get Your Digital Therapeutic Approved & Reimbursed in Europe and the U.S.

September 10, 2020, at 2 PM BST | 9 AM EST – REGISTER NOW Patients, providers, and payers expect healthcare to be more accessible, intuitive, and adaptable to their needs. Barriers that have held back innovation in Digital Medicine and Telemedicine have been blasted apart with the recent relaxing of CMS and HHS requirements, continuing […]

Pharma JAPAN 2020 (formerly eyeforpharma)

EVERSANA is proud to be a Global Sponsor at this year’s Pharma Japan 2020 (formerly eyeforpharma Japan), taking place on September 1-4. The healthcare landscape is evolving and pharma must evolve with it. From the Opening Keynote, focusing on the future direction of pharma with cutting-edge case studies, to the practical themes covering Digital Clinical Innovation, […]